Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

As European markets experience a lack of clear direction amid geopolitical developments and economic uncertainties, investors are increasingly on the lookout for stocks that may be trading below their intrinsic values. In this environment, identifying undervalued stocks involves assessing companies with strong fundamentals that have been overlooked or undervalued by the market, offering potential growth opportunities despite broader economic challenges.

Top 10 Undervalued Stocks Based On Cash Flows In Europe

Name Current Price Fair Value (Est) Discount (Est) Sanoma Oyj (HLSE:SANOMA) €9.15 €18.11 49.5% Robit Oyj (HLSE:ROBIT) €1.40 €2.77 49.5% Rheinmetall (XTRA:RHM) €1197.20 €2377.27 49.6% PCC Rokita (WSE:PCR) PLN67.70 PLN131.97 48.7% Netcompany Group (CPSE:NETC) DKK333.80 DKK665.18 49.8% Gabriel Holding (CPSE:GABR) DKK262.00 DKK512.19 48.8% Cint Group (OM:CINT) SEK5.77 SEK11.38 49.3% B&S Group (ENXTAM:BSGR) €5.85 €11.66 49.8% AUTO1 Group (XTRA:AG1) €22.48 €44.62 49.6% 11 bit studios (WSE:11B) PLN141.80 PLN281.71 49.7%

Click here to see the full list of 202 stocks from our Undervalued European Stocks Based On Cash Flows screener.

Below we spotlight a couple of our favorites from our exclusive screener.

New Wave Group

Overview: New Wave Group AB (publ) is involved in designing, acquiring, and developing brands and products across corporate, sports, gifts, and home furnishings sectors globally, with a market cap of SEK12.77 billion.

Operations: The company's revenue is primarily derived from its Corporate segment at SEK5.21 billion, followed by Sports & Leisure at SEK4.10 billion, and Gifts & Home Furnishings at SEK857 million.

Estimated Discount To Fair Value: 40.8%

New Wave Group is trading at SEK96.25, significantly below its estimated future cash flow value of SEK162.56, indicating undervaluation based on discounted cash flows. Despite a forecasted low return on equity and slower revenue growth compared to peers, earnings are expected to grow significantly at 20.2% annually over the next three years—outpacing the Swedish market's growth rate. However, dividends are not well covered by free cash flows, and debt coverage by operating cash flow remains inadequate.

Our growth report here indicates New Wave Group may be poised for an improving outlook. Click here to discover the nuances of New Wave Group with our detailed financial health report.OM:NEWA B Discounted Cash Flow as at Jun 2026

Ratos

Overview: Ratos AB (publ) is a private equity firm that focuses on buyouts, turnarounds, add-on acquisitions, and middle market transactions with a market cap of SEK11.10 billion.

Operations: Ratos generates its revenue through buyouts, turnarounds, add-on acquisitions, and middle market transactions.

Story Continues

Estimated Discount To Fair Value: 37.7%

Ratos AB is trading at SEK33.88, considerably below its estimated future cash flow value of SEK54.39, highlighting its undervaluation. Although the dividend yield of 4.13% is not well covered by earnings and return on equity remains low, the company is expected to become profitable within three years with an impressive annual earnings growth forecast of 61.91%. Analysts anticipate a stock price increase by around 20%, despite recent first-quarter net income decline to SEK193 million from SEK248 million last year.

Our expertly prepared growth report on Ratos implies its future financial outlook may be stronger than recent results. Take a closer look at Ratos' balance sheet health here in our report.OM:RATO B Discounted Cash Flow as at Jun 2026

AUTO1 Group

Overview: AUTO1 Group SE is a technology company that operates a digital automotive platform for buying and selling used cars online across several European countries and internationally, with a market cap of €4.95 billion.

Operations: The company's revenue is primarily derived from two segments: Retail, generating €1.93 billion, and Merchant, contributing €6.73 billion.

Estimated Discount To Fair Value: 49.6%

AUTO1 Group's current trading price of €22.48 is significantly below its estimated future cash flow value of €44.62, suggesting undervaluation. Despite a high level of non-cash earnings and volatile share price, the company shows strong potential with forecasted annual earnings growth of 36%, surpassing the German market average. However, its debt coverage by operating cash flow remains inadequate, which could pose financial risks despite positive revenue growth projections at 10.5% annually.

Upon reviewing our latest growth report, AUTO1 Group's projected financial performance appears quite optimistic. Navigate through the intricacies of AUTO1 Group with our comprehensive financial health report here.XTRA:AG1 Discounted Cash Flow as at Jun 2026

Where To Now?

Access the full spectrum of 202 Undervalued European Stocks Based On Cash Flows by clicking on this link. Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Contemplating Other Strategies?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include OM:NEWA B OM:RATO B and XTRA:AG1.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

As European markets navigate a period of uncertainty marked by economic contractions and fluctuating retail sales, investors are increasingly focused on identifying opportunities that offer attractive valuations. In this context, finding stocks trading below their estimated intrinsic values can be a prudent strategy for those looking to capitalize on potential market inefficiencies.

Top 10 Undervalued Stocks Based On Cash Flows In Europe

Name Current Price Fair Value (Est) Discount (Est) Talgo (BME:TLGO) €2.69 €5.21 48.4% Sanoma Oyj (HLSE:SANOMA) €9.10 €18.13 49.8% Rheinmetall (XTRA:RHM) €1207.20 €2368.27 49% PCC Rokita (WSE:PCR) PLN67.30 PLN132.17 49.1% Netcompany Group (CPSE:NETC) DKK340.20 DKK666.23 48.9% Hanza (OM:HANZA) SEK166.60 SEK330.80 49.6% elumeo (XTRA:ELB) €1.73 €3.41 49.2% Cint Group (OM:CINT) SEK5.75 SEK11.30 49.1% B&S Group (ENXTAM:BSGR) €5.85 €11.66 49.8% Bonesupport Holding (OM:BONEX) SEK225.40 SEK435.98 48.3%

Click here to see the full list of 203 stocks from our Undervalued European Stocks Based On Cash Flows screener.

Let's uncover some gems from our specialized screener.

ABIVAX Société Anonyme

Overview: ABIVAX Société Anonyme is a clinical-stage biotechnology company focused on developing therapeutics to stabilize the immune response in chronic inflammatory diseases, with a market cap of €6.84 billion.

Operations: The company generates revenue of €4.92 million from its research and development of pharmaceutical products aimed at stabilizing the immune response in chronic inflammatory diseases.

Estimated Discount To Fair Value: 40.9%

ABIVAX Société Anonyme is trading at €85.8, significantly below its estimated future cash flow value of €145.25, suggesting it may be undervalued based on discounted cash flow analysis. Despite recent shareholder dilution and a volatile share price, the company shows promising revenue growth forecasts of 59% annually, outpacing the French market average. Positive Phase 3 trial results for obefazimod in ulcerative colitis and plans for regulatory submissions further bolster its potential value proposition.

Upon reviewing our latest growth report, ABIVAX Société Anonyme's projected financial performance appears quite optimistic. Unlock comprehensive insights into our analysis of ABIVAX Société Anonyme stock in this financial health report.ENXTPA:ABVX Discounted Cash Flow as at Jun 2026

Helvetia Baloise Holding

Overview: Helvetia Baloise Holding AG operates in the life and non-life insurance, as well as reinsurance sectors, with a market cap of CHF19.75 billion.

Operations: The company generates revenue from three primary segments: life insurance at CHF2.10 billion, non-life insurance at CHF7.46 billion, and reinsurance contributing CHF509.50 million.

Story Continues

Estimated Discount To Fair Value: 38.3%

Helvetia Baloise Holding, trading at CHF199.4, is significantly undervalued relative to its estimated future cash flow value of CHF323.1. Despite recent shareholder dilution and a dividend not fully covered by free cash flows, the company reported net income growth to CHF552.3 million for 2025 and forecasts strong earnings growth of 29.6% annually, surpassing the Swiss market average. Recent fixed-income offerings enhance its financial flexibility amidst these dynamics.

According our earnings growth report, there's an indication that Helvetia Baloise Holding might be ready to expand. Click here to discover the nuances of Helvetia Baloise Holding with our detailed financial health report.SWX:HBAN Discounted Cash Flow as at Jun 2026

RENK Group

Overview: RENK Group AG specializes in the design, engineering, production, testing, and servicing of customized drive systems across various global regions including Asia, Germany, the United States, Africa, Australia, Oceania, and other European countries with a market cap of €5.16 billion.

Operations: The company's revenue segments include Slide Bearings at €127.49 million, Marine & Industry at €372.50 million, and Vehicle Mobility Solutions at €891.45 million.

Estimated Discount To Fair Value: 39.9%

RENK Group, trading at €51.57, is undervalued compared to its estimated future cash flow value of €85.75. The company's earnings are projected to grow significantly at 24.4% annually, outpacing the German market's 17.2% growth forecast. Despite high debt levels, RENK reported substantial first-quarter net income growth and confirmed revenue expectations exceeding €1.5 billion for 2026, indicating robust financial performance amidst favorable analyst price targets predicting a 32.1% rise in stock price.

The analysis detailed in our RENK Group growth report hints at robust future financial performance. Get an in-depth perspective on RENK Group's balance sheet by reading our health report here.XTRA:R3NK Discounted Cash Flow as at Jun 2026

Next Steps

Reveal the 203 hidden gems among our Undervalued European Stocks Based On Cash Flows screener with a single click here. Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Curious About Other Options?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ENXTPA:ABVX SWX:HBAN and XTRA:R3NK.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Während europäische Märkte die Komplexitäten geopolitischer Entwicklungen und wirtschaftlicher Anpassungen navigieren, haben Indizes wie der STOXX Europe 600 moderate Gewinne erzielt, während sich Investoren auf ein US-Iran-Abkommen freuen. In diesem Umfeld wird es für Investoren, die Chancen in unterbewerteten Vermögenswerten suchen, wichtig, Stücke zu identifizieren, die möglicherweise unter ihrem geschätzten Wert gehandelt werden. Ein gutes Unternehmen in solchen Bedingungen zeigt oft starke Fundamentaldaten und Resilienz gegen externe Schocks, was potenzielle Wachstumspotenziale trotz breiter Marktturbulenzen bietet.